Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCHW) Gross Profit (2022 - 2025)

Historic Gross Profit for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to -$363000.0.

  • Envoy Medical's Gross Profit fell 739.64% to -$363000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year increase of 117.16%. This contributed to the annual value of -$1.5 million for FY2024, which is 1177.78% down from last year.
  • Per Envoy Medical's latest filing, its Gross Profit stood at -$363000.0 for Q3 2025, which was down 739.64% from -$283000.0 recorded in Q2 2025.
  • Envoy Medical's Gross Profit's 5-year high stood at -$49000.0 during Q3 2022, with a 5-year trough of -$518000.0 in Q4 2022.
  • Over the past 4 years, Envoy Medical's median Gross Profit value was -$320000.0 (recorded in 2023), while the average stood at -$337230.8.
  • In the last 5 years, Envoy Medical's Gross Profit crashed by 55102.04% in 2023 and then surged by 3403.26% in 2025.
  • Over the past 4 years, Envoy Medical's Gross Profit (Quarter) stood at -$518000.0 in 2022, then increased by 19.31% to -$418000.0 in 2023, then decreased by 13.88% to -$476000.0 in 2024, then grew by 23.74% to -$363000.0 in 2025.
  • Its Gross Profit stands at -$363000.0 for Q3 2025, versus -$283000.0 for Q2 2025 and -$312000.0 for Q1 2025.